Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 223401 | Eutelsat Communications SA (E3B.HM) | XHAM | FR | 2025-06-30 | 3 days ago | EUR | 2.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223402 | Eutelsat Communications SA (E3B.HM) | XHAM | FR | 2024-06-30 | 10 months ago | EUR | 5.91 | 9.65 | 163.23% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223403 | Eutelsat Communications SA (E3B.HM) | XHAM | FR | 2024-06-30 | 10 months ago | EUR | 5.91 | 9.65 | 163.23% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223404 | Eutelsat Communications SA (E3B.HM) | XHAM | FR | 2024-06-30 | 10 months ago | EUR | 5.91 | 9.65 | 163.23% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223405 | Elicera Therapeutics AB (8E8.BE) | XBER | SE | 2024-12-31 | 1 month ago | SEK | 0.00 | 0.00 | 0.00% | 0.59 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223406 | Norbit ASA (4NK.BE) | XBER | NO | 2024-12-31 | 10 months ago | NOK | 0.00 | 34.75 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223407 | Prospect Resources Ltd (5E8.BE) | XBER | AU | 2025-06-30 | 3 weeks ago | AUD | 0.00 | 0.00 | 0.00% | 0.03 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223408 | Phaxiam Therapeutics SA (2E40.BE) | XBER | FR | 2023-12-31 | 5 months ago | EUR | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223409 | Phaxiam Therapeutics SA (2E40.BE) | XBER | FR | 2023-12-31 | 10 months ago | EUR | 1.90 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 223410 | Core Scientific Inc (7ZD.BE) | XBER | US | 2024-12-31 | 2 months ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |